BioSpace News Archive

CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance.

Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, announces today that The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland has approved the company’s application to start a Phase IIb study (HEAL) with LL-37 for treatment of venous leg ulcers.

Foundation Has Raised More Than $500,000 Since October to Bring Mobile STEM Laboratory to Schools Impacted by Hurricane Harvey.

Most people with diabetes and caregivers are found using finger-tip lancing techniques that are not consistent with best practices and also cause a tremendous amount of pain.

Koligo Therapeutics, Inc. today announced the formal introduction of KYSLECEL in the Eastern United States.

DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today that it has acquired TypeZero Technologies, Inc. (“TypeZero”).

Silony Medical is pleased to announce that it has performed its first lumbar cases in the US. Silony offers tailor-made sets of sterile pedicle screws ranging from 4.5 to 10.2mm width in 25 to 100mm lengths.

BD (Becton, Dickinson and Company) announced today that it will present at the Wells Fargo Securities 2018 Healthcare Conference on Wednesday, September 5, 2018, at 3:00 PM ET.

Reconstruction Cost Value of Homes in Extreme-to-Very High Risk Categories Total More Than $8 Billion

Medpace Holdings, Inc. today announced the pricing of the previously announced secondary offering of 5,224,997 shares of its common stock by investment funds affiliated with Cinven Capital Management